Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Daily Market Overview Dow Down 0.54 Pct Sp 500 Flat Nasdaq Up 0.17 Pct 20260328 1 Mir Stock Analysis Mirion Technologies Inc. 1.82 Daily Gain At 19 Dollar Outlook 20260403 Is Green Dot Gdot Stock Sensitive To Interest Rates Price At 11.18 Up 0.72 20260408 Is Foremost Fmst Stock Good For Long Term Price At 1.63 Down 1.21 20260409 Is Mitek Systems Mitk Stock A Value Play Mitk Q4 Earnings Beats Estimates By 0.07 20260413 1 Why AGNC Pfd C AGNCN is trading below its true worth 016 20260508 VTVT vTv Therapeutics Inc narrower than expected Q4 2025 loss pushes shares 373 higher on upbeat investor sentiment How Odyssey OMEX competitive position shows up in earnings Q1 2016 Better Than Expected What UDR UDR is doing that could pay off big later Ticks Lower 20260507 New Found NFGC Stock Swing Trade Setup Breakout Watch 20260420 HURC Hurco Companies shares gain 199 percent despite posting a 43 percent year over year Q1 2026 revenue decline Market Recap Tech outperforms consumer as indexes dip modestly Lineage LCTX Quarterly Preview Lineage reports 100 EPS beat on strong revenue Is Autolus AUTL building a durable competitive moat Rallies 20260511 Lowes Companies Inc LOW Peer Analysis Bullish Thesis for Floor Decor Holdings FND Amid Housing Cycle Volatility ICCC ImmuCell Corporation posts Q4 2025 negative EPS shares register a modest daily gain BrightView BV Macro Impact Q1 2026 EPS Misses Views Why SPAR Group SGRP might be early to something big Bearish Sentiment 20260508 DASH DoorDash posts Q4 2025 EPS 197 below consensus estimates shares edge down 072 in todays trading Precigen PGEN Q1 2026 Earnings EPS 002 Beats Estimates Kevin Warshs Preferred Inflation Measure Faces Skepticism from Bank of America Analyst Short Squeeze or Sentiment Rally SAIL Shares Surge 14 as Derivatives Pressure Mounts Opendoor Technologies OPEN Delivers Q1 2026 Beat EPS 003 vs 007 Expected Primis Financial FRST Q1 2026 Earnings 033 EPS Surges Past 029 Estimates Cass Info CASS Slips 073 Testing 4317 Support 20260515 Air Lease AL Unchanged at 6500 RangeBound Trading 20260515 CONMED CNMD Gains 316 Support Holds at 3478 20260518 Benchmark BHE Q1 2026 Earnings Beat Across the Board Trump Departs China After Trade Oil and Taiwan Dominate Talks Political Alliance Moves Signal Potential Policy Shifts Minister Adhav Arjuna Invites VCK IUML to Join TVK Cabinet BBB Foods TBBB Q1 2026 Results Fall Short EPS 476 Revenue NA SpaceX Scrubs Starship Test Flight Eyes Friday Launch for Starship V3 Debut Walmart Plans Price Cuts Using Tariff Refunds Amid Consumer Stress Bitcoin Drops to 745k Poised for Weekly Loss Amid Geopolitical Tensions Perpetua Resources Secures 29 Billion US Loan for Idaho Gold and Antimony Project Industrial Policy and Tariffs Global Imbalances Poised to Resurface CEPR Analysis Suggests Everest Group EG Q1 2026 Earnings Strong EPS Beat Amid Stable Underwriting Conditions PCOR Q1 2026 Earnings EPS Falls Short of Estimates Stock Edges Higher MSI Q1 2026 Earnings Strong Earnings Beat Amid Solid Operational Execution GE Q1 2026 Earnings Strong EPS Beat Amid Operational Momentum IPM Q1 2026 Earnings Significant EPS Miss Reflects Persistent Headwinds OilDri Corporation ODC Consolidates Near Key Support After Marginal Decline Strategy Inc Preferred Stock STRC Holds Steady Near Support Amid Low Volatility Bloomin Brands Stock Dips 243 Testing Support Levels Amid Market Pressures NAII Natural reports Q2 2024 revenue growth of 141 percent year over year shares rise 37 percent CVRX CVRx posts 104 YoY Q4 2025 revenue gain but slips 163 on narrow EPS miss GYRE Gyre Therapeutics Q4 2025 revenue rises 102 percent YoY misses EPS estimates as shares fall 228 percent MCRI Monarch posts 102 percent Q4 2025 EPS miss shares dip 092 percent amid soft investor sentiment How Lument LFTA earnings power stacks up historically LFTA Q3 Earnings Lument Series A Cumulative Preferred Stock Declares Dividend XTLB XTL highlights latestage drug pipeline progress in quarterly earnings prioritizes upcoming clinical trial readouts